Management Trainee

Programme
Agenda

• What we do…
– About Ranbaxy Group

• How we do it…
– Ranbaxy Advantage

• How you fit in...

– The Management Trainee Program
What we do……
An Overview

• Among India’s largest pharmaceutical companies

• Ranbaxy & Daiichi Sankyo combined rank among the top 20 global pharmaceutical
companies

• Worldwide Presence

• Ground presence in 46 countries, products sold in over 125 countries

• Manufacturing locations in 7 countries

• Global consolidated sales – US $ 1519 Mn (2009)

• Highest R&D spender amongst Indian Pharmaceutical companies

• Business

- International 77%
- Domestic 23%
• Around 14000 employees globally represented by 50 nationalities
Where we operate
Ranbaxy – Daiichi Sankyo Partnership

• A path breaking confluence that redefines the global pharma paradigm

• Strategic combination creates an Innovator and Generic Pharmaceutical Powerhouse

Global Pharma Innovator Global Generics Company

• Significant and sustained operational and strategic synergies

across the globe
– Collaborative marketing opportunities leveraging
Hybrid Ranbaxy’s substantial footprint
– Manufacturing
Business – R&D
Model – Global supply chain
– IT functions

• Combining innovator and generics capabilities, to straddle full

spectrum of pharma value chain
Ranbaxy Corporate Office

Our state-of-the-art Head Quarters is located at Gurgaon, New Delhi NCR

The ‘Brain Center’ for all our Global Strategies
 Vision, Mission & Values
Mission
• To become a Research-based International Pharmaceutical Company”

Vision 2012
• Achieve significant business in proprietary prescription products by 2012 with a strong
presence in developed markets
Values

• Achieving customer satisfaction is fundamental to our business

• Provide products and services of the highest quality

• Practice dignity and equity in relationships and provide opportunities for our people to
realise their full potential

• Ensure profitable growth and enhance wealth of the shareholders

• Foster mutually beneficial relations with all our business partners

• Manage our operations with high concern for safety and environment

• Be a responsible corporate citizen

Research & Development

• Dedicated Facilities for Innovative & Generics Research

• More than 1200 R&D Personnel

• Highest R&D spender amongst Indian Pharmaceutical companies

• NDDS based products (4 platform technologies)

• NDDR - Arterolane + PQP (Anti malaria)

• One program with GSK (Respiratory)

Collaboration in Clinical Development of NCE

• R&D collaborations with Industry & Academia

Research & Development
State-of-the-art R&D facilities based in Gurgaon (India)

R&D I R&D II R&D III

R&D IV R&D V R&D VI

Global Manufacturing Strengths

• cGMP compliant world-class API & Dosage Forms manufacturing

facilities across the globe

• 7 manufacturing locations worldwide

• API facilities - increasing vertical integration

• Creating capacities for specialty products

• New facilities added in cost advantageous geographies

Global Manufacturing Strengths

USA Ireland Romania Nigeria

India South Africa Malaysia

Key Strengths

• The aptitude
of our people
• Our • Confidence
innovative in our
use of expertise
technology

• Knowledge • Our ability

of our to react
markets swiftly

• Empowerment • Calculated
& risk taking
Independency ability

Ranbaxy is the partner of choice

Global Sales Split

CIS*

Asia
86 Mn
6% 441 Mn
29%

North
America 397 Mn
26%
214 Mn
14%
RoW
269 Mn 112 Mn
18% 7% All figures in US $

Europe API

US $ 1519 Mn (2009)
* CIS includes Russia & Ukraine belt
How we do it ...
Global Pharmaceutical Landscape

Global Pharma Market Slice

Global Pharmaceuticals Market:
US $ Bn
• 2009: ~ US $ 727 Bn (+5.7%)

33 Global Generics Market:

80
• 2009: US $ 83 Bn (+7.7%)
316
152

Key Drivers of Generics:

226
Significant patent expiries (~US
$ 80 Bn drugs) through 2012
• Increasing generic penetration
• Rationalizing healthcare costs
• Emerging markets opportunity
North America Europe
Africa, Asia and Australia Japan
Latin America

Source : IMS Mat Nov 2009

 Advantage India

GROWTH IN THE DOMESTIC MARKET & STRONG INDUSTRY FUNDAMENTALS

India will be the 10th largest pharma market by 2015 with drivers
like:
• Epidemic of ‘Lifestyle’ illnesses
• Medical Infrastructure, Affordability & Healthcare Reach
• India is the Global Pharma Outsourcing Hub
• Enhanced clinical research capabilities
• Large talent pool
• Treatment Naïve patients
• High quality standards for trials
• Strong manufacturing backgrounds
• Largest # of US FDA approved plants outside the US  61
plants
• Large pool of API & Finished Dose formulation
• manufacturing facilities
• India is 3rd largest API manufacturer with  USD 2 Bn
• 40% of US DMF filings from India
• Low cost & high quality of manufacturing

Source: IMS Health: MIDAS, MAT Dec 2006 & IMS World Review; Analyst projections;
McKinsey India Pharmaceutical Demand Model, India – Includes institutional sales
The Global Generics Advantages
Growth Potential
• Patent Expiries
• New Markets
• Healthcare Costs

Consolidation India Factor

• Size & Scale • Scientific Talent
• Therapeutic • Cost Advantage
Width
• Gx / Rx
• Operational
Synergies • Competencies

Product Portfolio
• Pressure on Vanilla Gx
• Move to Specialty/ Niche
 Ranbaxy Business Model

Global Reach Product

Developed Markets
North America, EU, Portfolio
Japan, Australia • Generics,
• Branded Generics
Emerging markets • OTC
India Romania, CIS
South Africa, Brazil
Mexico

Research & Manufacturing

Development
• Generics/NDDS*
• Complex/Niche/FTF*
• Select New Chemical
Entities
• Dosage Form
• API * - Vertical Integration
• In-house/Outsource

* NDDS – Novel Drug Delivery System, API – Active Pharmaceutical Ingredients, FTF – First to File
Competitive Advantage @ Ranbaxy

Aggressive Manufacturing R&D

Marketing Efficiencies Capabilities
Labor Skilled Scientist Pool
Highly competitive
- Generics
domestic market Infrastructure - Innovative Research
Global Quality Standards Process Chemistry
Expertise

Competetive cost, innovative and high quality product flow

Global Head Quarter INDIA

o Among India’s largest pharmaceutical companies

o One of the largest distribution networks that comprises over 4000

field force

o Dedicated task forces for specialized & chronic therapies

o 18 brands in Top 300 of Industry

o Project ‘Viraat’ – A key initiative to strengthen company’s

domestic leadership position
Developed Market Presence

• Largest generic market worldwide

• Significant patent expiries through 2012
USA

• Germany, UK - mature markets

• France, Spain, Italy, Romania - emerging markets
• Ranbaxy has presence in 23 of the 27 EU countries
EU

• Mature generic market

• Ranbaxy is the fastest growing generics company in Canada
Canada

• Emerging generic market, < 5% generic penetration

• 1st Indian pharma company
Japan
Emerging Markets Presence

• Among India’s largest pharmaceutical companies

• Growing at a fast pace
India

• Ranked as the No. 1 Generics Company

• Strategic for servicing EU operations
Romania

• Strong base in acute therapies

• Fast expanding into chronic and OTC segments

Russia &
Ukraine

• Key market in the African continent

• A strong No. 5 player in the region
South Africa
Inorganic Strategy

To capitalize on the opportunities in the ongoing consolidation for…

• Size and scale in developed & emerging markets

• Expansion of geographical reach

• Access to niche and complex products / therapeutic areas

• Costs efficiencies in manufacturing and R&D

... providing a strategic and value accretive fit

Key Acquisitions & Alliances
More than US $ 500 Mn spend on M&A

OTHER COUNTRIES INDIA

* Terapia (Romania) * Zenotech

*
*
*
Be-Tabs(South Africa)
Allen (Italy)
Mundogen (Spain) $ * Cardinal Drugs
* Ochoa Labs
* Biovel
Corporate Social Responsibility
Ranbaxy Community Healthcare Services founded in 1979

It has an
integrated
approach

* Preventive Covering areas of :

* Maternal Child Health
* Promotive
* Family Planning
* Curative
* Reproductive Health
Services
* Adolescent Health
* Health Education
* AIDS awareness
Corporate Social Responsibility

• Corporate Social Responsibility is inscribed in our VALUES

• Ranbaxy Rural Development Trust set up in 1978 (later re-christened
as ‘Ranbaxy Community Health Care Society’)
• We serve about 2 lakh people staying in 110 villages and urban slum
areas; of Punjab, Haryana, Himachal Pradesh, Madhya Pradesh
• Launched Mobile Healthcare services : infrastructure includes 14
Mobile Health Care Vans
• Public Private Partnership (PPP) with the Punjab State Government, to
deliver healthcare services in identified districts of Punjab. The program
- Ranbaxy Sanjeevan Swasthya Seva - is being rolled out in a phased
manner
• Partnered with State & Central Government of India in critical areas
HIV/AIDS, tuberculosis, Malaria, Polio, non-communicable chronic
diseases and female foeticide.
Management Trainee Programme
Multifaceted Interaction
Cross Functional Team & Corporate HR
Steering Committee Conducts/ facilitates
(All Mentors) Management Trainee
Coach Trainees, removes programme. Acts as
Roadblocks, conducts sounding board
assessments,
Finalizes placements and set
Direction for the program.

Management
Trainees –
Accountable for
learning & delivery
Business/Functional
Head
Acts as guide –
Agrees projects with
his/her team & is
responsible for
direction, support &
assessment
MTP @ Ranbaxy

Purpose
Process
The purpose of the
programme is to help
the MT to experience The programme focuses predominantly on
the various facets of experiential learning through on the job
Ranbaxy and thereby programmes. This is achieved through
prepare for the  Basic understanding of the business through
assigned role lectures and interactive sessions
 Project work in various areas of the key
function, across different locations
 Self-awareness sessions
 Self development with training on key
behavioral attributes
The Programme
Total Duration of MT: 12 months with 3 Rotations
Induction
Induction provided by Corporate HR
First 15 days
Objective:-Induction helps MT to
Informal Review of Progress know about Ranbaxy as an
organization, its culture, values, ethics
and company vision & mission

Project Assignment 1
Project provided by respective assigned
Next 3 and a
department half months Objective:-Provide platform for
the MT to get familiarized with the
Review of Progress by Coach/Manager functioning of assigned area of
interest & accelerate learning curve

Project Assignment 2 & 3 Last 8 months

Project suggested by respective department
but in different locations
Objective:-Provide an in-depth
understanding of the function at
different locations
Review of Progress at the end of 12 months

First 18 months
Suggested Career Ladder - Illustrative

Cross
Functional
Exposure

International
Assignment

Continuous
Development
Opportunity

Competitive
Pay Packages
A B C D E

Job Class Progression Diversity

Some of Our Graduate Top Achievers...
Current
Name Function Area Batch Institute Name
Designation
Director - Business Business Solutions
Neeraj Kukreti 1995 FMS
Solutions Group
Corporate
Sandeep Juneja Director - M&A 1994 IIFT
Development
Pharma
Anupam Bhatt Director - HR 1990 XISS
Manufacturing
K. Venkatachalam Sr. VP & RD Ranbaxy Inc. (USA) 1993 SPJ
GM-Global Hybrid Global Hybrid
Abhimanyu Ojha 2002 IMI
Business Business

GM-Production Sydenham Institute of

Hemant Dhondge Global Supply Chain 1993
Planning Bombay University

Product Manger -
Karan Khambati CIS 2006 NMIMS
Ukraine
Poonam Bharti GM-HR R&D 1995 TISS
Global Material Symbiosis Institute –
Ravi Natarajan GM-Materials 1990
Sourcing Poona University
Selection Process

Recruitment through campus selection process in business

Schools

 CVs short listed as per the predefined parameters

 Group Discussion
 Personal Interview
 Psychometric Test for short listed candidates
 What we offer
• Earning Potential (CTC) up to Rs. 9,58,660 annual
• Performance driven career growth

• Growth through Continuous Learning

• Opportunity of working with a Global Pharma Major in the fast paced Pharma market

• One Time Relocation Expenses: Rs. 25,000/-

• Fixed Total
• Includes Stipend, Subsidies – House
Rent, Conveyance, Education, Utility, Medical, Leave Travel, Bonus, Telephone, Hard
Salary Furnishing, Retirals

Details • Variable pay

• Other Benefits
• Group Hospital Insurance around Rs. 1.20 lac per annum for per declared dependent
(immediate family)
• Group Term Insurance – Varies (based on eventuality) – up to maximum of Rs. 9.50 lac
Questions
 Next Steps

Step 1: Read more about the organisation from official website www.ranbaxy.com
Step 2: All the candidates have to go through the entire selection process and final selection
will be the sole discretion of the organisation.
Step 3: Dates for campus recruitment will be communicated to the Placement Coordinator
Step 4: For any query please route through your respective Placement Coordinator

Step 5: Offer will be treated final only after receiving written confirmation from the
organization
Step 6: The offer of appointment is subject to your successful completion of company’s
medical examination and verification of your testimonials/certificates
Step 7: One year training will start from June 1, 2011
Step 8: For any clarification related to MT Programme, Training, joining and other related
matters please contact at MTP@ranbaxy.com
Disclaimer
• This presentation includes forward-looking statements. Such statements are only
predictions and actual events or results may differ materially. For a discussion of
important factors which could cause actual results to differ from the forward-looking
statements, please refer to Ranbaxy Laboratories Limited Annual Report and
Accounts

• Nothing in this presentation constitutes or shall be taken to constitute an offer,

invitation or inducement to any person to invest in Ranbaxy and no reliance should
be placed on the information contained in it in connection with any investment
decision or for any other reason. Ranbaxy Laboratories Limited and its affiliates do
not make any representation or warranty, express or implied, with respect to the
completeness, adequacy or accuracy of the information contained in this
presentation
THANK YOU